chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Headache started the day after vaccine and continues daily. Pain as high as 13 on a scale of 1-10.  Today, he reports H/A comes and goes now instead of continuous but 4-5x/day. Today around noon he laid down about 15 minutes after it started and it went away. Will schedule appt w/PCP tomorrow.
ACHES; CHILLS; FEVER; FATIGUE; This spontaneous report received from a patient concerned a patient of unspecified age and sex. The patient's height, and weight were not reported. The patient's past medical history included: covid-19. The patient received covid-19 vaccine (suspension for injection, route of admin not reported, batch number: Unknown) dose was not reported, administered on 24-AUG-2021 for prophylactic vaccination. The batch number was not reported and has been requested. No concomitant medications were reported.  On MAR-2021, Laboratory data included: Antibody test (NR: not provided) Positive. On 24-AUG-2021, the patient experienced aches. On 24-AUG-2021, the patient experienced chills. On 24-AUG-2021, the patient experienced fever. On 24-AUG-2021, the patient experienced fatigue. Treatment medications (dates unspecified) included: acetylsalicylic acid, and paracetamol. The action taken with covid-19 vaccine was not applicable. The patient was recovering from fever, aches, chills, and fatigue. This report was non-serious.
Woke up after a couple hours of sleep, experienced severe sudden onset of sciatic type pain on right side hip-pain shooting down leg when try to put weight on right foot. I was going to go to freezer to get an ice pack for the injection arm which was hurting. Unable to do normal activities following day. Pain still exists today (12/13). Self treatment with ibuprofen and ice compresses, stretching exercises. Will need dr appt. if does not improve
bottom ofhis feet started hurting and continue to hurt; This is a spontaneous report received from non-contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 57-year-old male patient received BNT162b2 (BNT162B2), as dose 2, single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. Vaccination history included: Bnt162b2 (Dose Number: 1, Batch/Lot No: Unknown. Not available/provided to reporter at the time of report completion), for COVID-19 immunization. The following information was reported: PAIN IN EXTREMITY (non-serious), outcome "not recovered", described as "bottom ofhis feet started hurting and continue to hurt". It was unknown if therapeutic measures were taken as a result of pain in extremity.  Additional information: This report was about COVID Vaccine. Patient did receive the vaccine. Lot number was unknown because not available/provided to reporter at the time of report completion. It was unknown whether the patient received other vaccine in four weeks. It was unknown about covid prior vaccination. It was unknown whether covid tested post vaccination  No Follow-up attempts are possible. Information about lot/batch cannot be obtained. No further information is expected.
Vomited 5 min after vaccine and began to have burning in throat. Pt is employee and did not report symptoms until 1 hour later. Then she also had audible sneezing. 17:35 exam room, unable to obtain B/P, tachycardia, experienced wheezing throughout lungs. Benadryl 50mgml PO at 17:40. Ambulance called. Pt vomited. Albuterol given. O2 given. Epinephrine at 1:1000, 0.3ml IM at 18:00 and Benadryl 50mg ml IM. Vomited again. Breathing worsened, unresponsive x 30 seconds, mouth to mouth given. Ambulance arrived. IV started. Transferred to ER. Admitted to ICU. Pt had 2 more episodes of unresponsiveness, during hospitalization.  Nurse follow up on 10/30/04 states: "anaphylactic shock; Flushed; Ventricular tach; Arrhythmia; seizure; vagal reaction; tingling; stridor; pallor; urinary retention; insomnia
High Fever, Febrile Seizure, rash on entire body, fatigue, pale, blisters in mouth, swollen glands.
Increased T, itching, whelps entire body, tightness in chest, swelling of hands. Tx with IM injection & PO med.
1st dose Dec2020, no 2nd dose yet; This case was reported by a pharmacist via call center representative and described the occurrence of incomplete course of vaccination in a 71-year-old female patient who received Herpes zoster (Shingrix) for prophylaxis.   Previously administered products included Shingrix (1st dose received on 28th December 2020).   On an unknown date, the patient received the 2nd dose of Shingrix. On an unknown date, unknown after receiving Shingrix, the patient experienced incomplete course of vaccination. On an unknown date, the outcome of the incomplete course of vaccination was unknown.  Additional details were provided as follows: The age at vaccination was not applicable for this report. The pharmacist reported that the patient was late for their second dose of Shingrix and till the time of reporting, the patient did not receive 2nd dose, which led to incomplete course of vaccination. The reporter consented to follow up (email).
This spontaneous report as received from a pharmacist refers to a currently 55 year old female patient with no drug reactions/allergies and with a prior history of shingles. On 16-JUL-2013, the patient was vaccinated with a dose of ZOSTAVAX, 19400 PFU (lot# and expiry not reported), 0.65 ml, subcutaneous. Concomitant therapies included Omeprazole (manufacturer unknown), KLONOPIN and Simvastatin (manufacturer unknown). The pharmacist reported that the patient had developed shingles 3 times on unspecified dates since receiving ZOSTAVAX. The pharmacist reported the patient was seen by her physician on an unspecified date. The patient was prescribed acyclovir a "couple days ago". The outcome of the event was unknown. Additional information has been requested.
nerve irritation; herpes zoster; herpes simplex; postherpetic neuralgia; Information has been received from a lawyer and a consumer regarding a case in litigation referring to a patient (pt) of unknown age or gender. The pt's concurrent conditions, medical history and concomitant medications were not reported. On or about 10-JAN-2013 and 21-NOV-2013, the pt was inoculated with zoster vaccine live (ZOSTAVAX) (dosage regimen, route of administration, anatomical location, lot number and expiration date were not provided)at the health center for the long-term prevention of shingles and zoster-related conditions. Subsequently, the pt was treated by health care providers for the following injuries resulting from the use of zoster vaccine live (ZOSTAVAX): herpes zoster, postherpetic neuralgia, herpes simplex and nerve irritation. The outcome of the claimed events was not provided, and causal relationship was reported as related to zoster vaccine live (ZOSTAVAX).
Temp 104.2, redness & swelling at injection site, headache, stomach ache, tired, chills, body aches, sore joints.
Right after getting the shot I felt like my left side of my throat was closing. The next day I woke up and my right eye was bloodshot and itchy. Two days after the shot I got a rash on my right forearm.
Severe abdominal issues, blood pressure went up to 210/110, had to go on blood pressure meds to lower it, major pressure in the back of my head into my ears, down my neck, passed out, heat sensations, dizzy, lightheadedness, tingling in arms and legs, numbness, inside tremors, nystagmus,  trouble swallowing, a hoarse voice, muscles twitching, eyesight bad, poor memory,  bubbles and clicking noises in base of back of head.
Menveo dluted with sterile water and administered; Menveo dluted with sterile water and administered; This case was reported by a pharmacist via call center representative and described the occurrence of wrong solution used in drug reconstitution in a 16-year-old male patient who received Men ACWY-CRM NVS (Menveo) (batch number AMVA710A, expiry date 30th April 2023) and (batch number T014300, expiry date unknown) for prophylaxis.   On 16th August 2022, the patient received Menveo. On an unknown date, the dose was an unknown dose. On 16th August 2022, unknown after receiving Menveo, the patient experienced wrong solution used in drug reconstitution and inappropriate dose of vaccine administered. On an unknown date, the outcome of the wrong solution used in drug reconstitution and inappropriate dose of vaccine administered were unknown.    Additional Information: GSK receipt Date: 17-AUG-2022 Reporter's comment: The reporter stated that, they accidentally diluted Menveo with sterile water and administered it to patient. The reporter consented to follow up. Additional Supportive Information: The reporter stated that, they accidentally diluted Menveo with sterile water and administered it to patient, which led to wrong solution used in drug reconstitution and inappropriate dose of vaccine administered. This was 1 of 2 cases reported by the same reporter. Note: Two batch number were reported one for the liquid conjugate (AMVA710A) and other for lyophilized conjugate (T014300).; Sender's Comments:  US-GSK-US2022120204:Same reporter
This spontaneous report was received from a supervisor, referring to a currently 2 years old male patient. The patient's historical drugs, medical history, drugs allergies and concurrent conditions were not reported. The patient's concomitant therapies included sterile diluent. On 21-FEB-2019, the patient was vaccinated with an improperly stored dose of VARIVAX subcutaneously, lot# R018142 and expiration date 25-JUN-2020, for prophylaxis (strength, dose and frequency were not reported). The temperature excursion was of 6 Fahrenheit degrees (degrees F) to 14 degrees F, during 2 hours 20 minutes. However, a previous temperature excursion of 15 degrees F to 46 degrees F for 11 hours was also reported. A digital data logger was involved. No adverse effects were reported. Sender's Comments: US-009507513-1903USA000678; US-009507513-1902USA012055; US-009507513-1903USA000677; US-009507513-1903USA000680; US-009507513-1903USA000681; US-009507513-1903USA000683; US-009507513-1903USA000684; US-009507513-1903USA000685.
I had this reaction to both shots: chills, fever, whole body muscle aches, headache, general malaise,  sore arm, large red circle at site....lasting 2.5 days with still some mild symptoms present.
customer became pale, unable to respond to external stimuli, diaphoretic while sitting in waiting area directly after being given vaccine
Following the 2nd dose, patient felt a "heaviness in chest." March 11th, two days post-vaccination, patient was admitted to hospital via ambulance due to shortness of breath-difficulty breathing. Tests were run, and health continued to decline. Doctors suggest an autoimmune reaction due to vaccine, which then exacerbated her COPD. They found fluid inner lungs.
Toddler received influenza vaccine to right thigh (also received Hib to right thigh - 3/3 dose), VARIVAX to left thigh. Several hours after vaccination, he became less playful, not wanting to stand. During the night awoke with fever 102-104. On 10/10/18 temp (102) and increasing discomfort noted by Mother with moving to right leg - increasing refusal to weight bear. Child was seen in the office - pain localized to right hip - no redness/swelling warmth noted to injection sites or to joints of right leg. Obvious discomfort noted with any attempt to abduct/adduct right hip. Toddler noted to cry in pain with weight bear - very reluctant to toe touch with right leg. Labs/xray obtained on 10/10/18 - last reported temp at 1 pm on 10/10 of 102.
Received booster dose earlier than 6 months after 2nd dose of Pfizer COVID vaccine.
Initial unsolicited report received from a consumer on 8 April 2016. This case involves a female patient (age not reported) who was vaccinated with a dose of (TD) (dose, dose in series, batch number, route and site of administration was not reported) on an unspecified date 10 years ago. Patient's medical history and concomitant medications were not reported. On an unspecified date (10 years ago), following the vaccination, the patient's arm swelled almost twice the size and was red. She could not lift her arm the next day. Patient required emergency room/physician visit. Patient's lab data and corrective treatment were not reported. Few days after onset, the patient was recovered from the events. List of documents held by sender: none.
On the 4th - woke up weak; light headed; and a lot of discomfort - his arm really hurt. General body achiness. After a little while, he got up and was able to take some Tylenol and attend his video school day with frequent breaks. In afternoon, he started to feel worse. 102. 6 fever - we called Tele-doc appt. His throat was sore and he had some chest pain. The doctor recommended that we go to ER to have him fully evaluated. Pain and fever got better with the Tylenol. He took another couple of dose. Next morning, he had a lot better but continued to have a low fever 100.2 - on and off that day. His lymph nodes under his left arm were quite swollen and painful. The fever did not continue yesterday but the swelling has and the pain has. He was very light-headed and brain fogged on Sunday and Monday. Seems to be better today - the lymph nodes have gone down a lot but are still swollen today. He is  in process of recovering.
Erythema, swelling, fever, hot to touch at area of vaccination. Appears similar to cellulitis. Sent to Occ med. opened Worker comp claim.
Pt was accidentally administered an expired vaccine. The vaccine was expired by 2 days. Pt did not report any issues immediately after the vaccination.  RN will follow up with him tomorrow as well.
Noticed that not only did I had redness, soreness and swelling at the site of the injection, but the redness, itching, discomfort traveled down past my elbow. Due to the Friday being Good Friday, and the clinic was closed, I called the urgent clinic I usually go to and was told I needed to be seeing, was diagnosed with cellulitis. Was prescribed Keflex, 1,000 mg three times a day. Arm is much better now, although continues to itch a bit.
elevated blood pressure (150-172/80)/headache/queezy/diarrhea (within one hour after vaccination patient reports)
felt swelling at the back of her sinus; This is a spontaneous report from a contactable pharmacist. A 57-year-old female patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number EH9899) intramuscular on 21Dec2020 at a single dose in the left arm for COVID vaccine. Medical history and concomitant medications were not reported. She had no other vaccine received in four weeks. It was reported that on an unspecified date, the patient felt swelling at the back of her sinus after having her last COVID vaccination. Lab data included prior allergy testing with unknown results on an unspecified date. Treatment for the event was noted as antihistamine. It was unknown if the patient had COVID prior vaccination and also unknown if she had COVID tested post vaccination. The outcome of the event was recovered on an unspecified date.
PT RECIEVED ANTHRAX VACCINE ON 27 AUG 08, ON 28 AUG 08 @ APROX. 1700 PT BECAME HAD EXTREME NAUSEA AND FATIGUE THAT LASTED UNTIL APROX 1200 HRS ON 30 AUG 08.
12/19/22  I started having pain in my chest and back. I was tired. The next day, I continued with these symptoms.  That night I started worrying it could be a pulmonary embolism. The next day, I was lightheaded when I stood up so I went to the Emergency Room on 12/21/22. It was confirmed I had a DVT and a pulmonary embolism. (I had foot surgery on 12/9/22, unrelated.) I was tested for COVID in the Emergency Room on 12/21/22 and it was positive. I was told it was provoked due to the combination of the foot surgery and I was at increased risk because of having COVID.  I was admitted to the hospital overnight.  I started on Eliquis and took it for 3 months. I have had no symptoms or blood clots since.
Pt vaccinated with DTP/OPV/HIB and experienced 24 hrs of irritability and screaming.
equipment failure. Dose leaked out at top of syringe(where needle attaches to syringe barrel). It was determined that less than 1/2 of the dose was administered. We contacted manufacturer and they sent us documentation that we should administer the dose again immediatley in the opposite arm. We administered the dose at 3:00pm  in the right deltoid.
Herpes zoster eruption on arm confirmed by PCR for varicella zoster virus.
Information has been received from a physician concerning an 8 year old female who on 31-MAY-2001 was vaccinated with her first dose of VARIVAX (Oka/Merck) (lot number 637672/1610K, route and site not reported). Concomitant therapy included her first dose of MMR II and the third dose of COMVAX. On 30-JAN-2009 the patient developed chickenpox. The physician reported that they were unsure if the patient will be getting the booster of VARIVAX (Oka/Merck). No further information is available.
Continuous heart palpitations and localized pain in upper left chest. Head aches joint stiffness that do not subside with movement or exercise.  Sleep disturbances
Sick; I half the second shot; This case was reported by a consumer via call center representative and described the occurrence of sickness in a adult patient who received Herpes zoster (Shingrix) for prophylaxis.   The patient's past medical history included chemotherapy.   On an unknown date, the patient received the 2nd dose of Shingrix. On an unknown date, unknown after receiving Shingrix, the patient experienced sickness and underdose. On an unknown date, the outcome of the sickness was not recovered/not resolved and the outcome of the underdose was unknown.   It was unknown if the reporter considered the sickness to be related to Shingrix.  Additional details were provided as follows: The age at vaccination was not reported. The age group was not reported but was selected as adult as per vaccine indication.  The patient received half the second shot which led to underdose and patient became sick. The reporter inquired how long did  the sued effects last.
Within 2 hours after the shot, my arm became sore and warm to the touch.  Within 36 hours, this went away.  no other bad effects.  Then, around the first of May (about a month after the shot), the injection site became sore again.  This also happened to my business partner who was vaccinated on the same day. He took the Moderna vaccination.  The injection site is still sore on both of us, feeling like we have been knuckle punched in the arm all the time.  I haven't done anything to injure my arm.  I also have tendonitis in my groin, but don't particularly think that is related to the virus.  I am just telling you so that if that is part of a larger pattern, you will have recorded it.
Injection given into (L) deltoid IM. 24 hrs later there was a large swelling 150% of normal arm circumference, hot painful with some radiation to (L) shoulder. No abscess or drainage or necrosis, no sign of infection.
Woke up at 1:30 am with severe chills, shivering uncontrollably.  Had to put layers of clothes and blankets on to get warm.  As of 5:30 am he is running a fever.  Temperature unknown, due to thermometer not working.  Chills and shivering have abated, and ibruprophen was given for fever.
Pt c/o not feeling well 10-15 minutes after injection given. She c/o tightness in chest and an odd sensation in her jaw. Pt was asked to sit. Her BP was taken 4x until symptoms resolved. Her MD was notified and pt was asked to follow up w/MD. Symptoms resolved in 45 min.
Slight blurry vision - laid dawn for 2 hours, blurry vision went away.
Pt recvd vax & exp hives which were ongoing through dose 2; treated w/DPH & have not resolved;
On day 8 after the first dose, a large, red, and hot lesion an inch below the injection site.
pt recvd vax;mom noticed occasionally pt's head would sum to drop forward & eyes would blink at the same time;approx 6 days after vax,sxs seemed more obvious;to MD for exam;sxs last observed 3nov or 4nov & have not been seen since;
expired doses administered; This spontaneous case was reported by another health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (expired doses administered) in a 63-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 012H21B) for COVID-19 vaccination.     No Medical History information was reported.    On 06-Jan-2022, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 06-Jan-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (expired doses administered). On 06-Jan-2022, EXPIRED PRODUCT ADMINISTERED (expired doses administered) had resolved.      For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant and treatment medications were reported. It was reported total 69 administered doses of these 68 doses were booster and one were 1 dose.
Reaction to moderna (Over 35 days from 1st dose); This spontaneous case was reported by a patient family member or friend and describes the occurrence of VACCINATION COMPLICATION (Reaction to moderna (Over 35 days from 1st dose)) in a 20-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    In February 2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. In March 2021, the patient experienced VACCINATION COMPLICATION (Reaction to moderna (Over 35 days from 1st dose)). At the time of the report, VACCINATION COMPLICATION (Reaction to moderna (Over 35 days from 1st dose)) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medication is reported No treatement of maedication is reported The caller's 20 year old son received his 1st shot  in Feb 2021.
the vaccine was expired when administered to the patient with no reported adverse event; Initial information received on 29-Jan-2023 regarding an unsolicited valid non-serious case received via health professional.  This case involves 11 years old Child and unknown gender patient to whom expired vaccine DIPHTHERIA-2/TETANUS/5 AC PERTUSSIS VACCINE [ADACEL] was administered with no reported adverse event.  It was unknown if the patient had any medical history, concomitant disease, or risk factor. The patient's past medical treatment(s), vaccination(s) and family history were not provided.   On 27-Oct-2022, the patient received expired vaccine suspect Diphtheria-2/Tetanus/5 AC Pertussis Vaccine Suspension for injection at dose 0.5 ml total (lot: C5787AA, expiry date:  27-Oct-2022) via unknown route in the left arm for prophylactic vaccination with no reported adverse event (expired product administered) at same day.  Action taken: Not applicable.  At time of reporting, the outcome was Unknown for the event expired product administered.  This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in the guidelines. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.
pt recvd vax;to clinic c/o soreness & redness at inject site;returned again on 11aug94 w/ flu-like sxs including T 99.3 & a red rash on face & neck;
Given PNEUMOVAX ON 09/19/08 LT deltoid. came to office 09-21-08 12 cm redness, warmth, 3cm area of induration (+) blanchable 150 mg x 7 days. Heat to area 2x a day.
Localized induration and erythema on rt arm - HPV and VAR. Diameter of 2in. Warm compress 20min TID and IB. May last for 1wk.
Day of administration patient reported a headache and arm ache which was relieved with ibuprofen and next day a rash developed for 2 days all symptoms resolved in 4 days.
Severe lower back pain that radiates to bilateral hips, has been in pain since Friday around 8 PM.  Patient does not wish to come in to clinic for appt. States that he read about it online and it should only last around